Page last updated: 2024-10-30

labetalol and Hypercapnia

labetalol has been researched along with Hypercapnia in 1 studies

Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.

Hypercapnia: A clinical manifestation of abnormal increase in the amount of carbon dioxide in arterial blood.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schroeder, T1
Schierbeck, J1
Howardy, P1
Knudsen, L1
Skafte-Holm, P1
Gefke, K1

Other Studies

1 other study available for labetalol and Hypercapnia

ArticleYear
Effect of labetalol on cerebral blood flow and middle cerebral arterial flow velocity in healthy volunteers.
    Neurological research, 1991, Volume: 13, Issue:1

    Topics: Adult; Blood Flow Velocity; Blood Pressure; Cerebrovascular Circulation; Humans; Hypercapnia; Labeta

1991